Concomitant use of an immunomodulator with ustekinumab as an induction therapy for Crohn's disease: A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Concomitant use of an immunomodulator with ustekinumab as an induction therapy for Crohn's disease: A systematic review and meta‐analysis

Published:2021-02-03 Issue:7 Volume:36 Page:1744-1753
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Yoshihara Takeo¹,Shinzaki Shinichiro¹,Amano Takahiro¹,Iijima Hideki¹^ORCID,Takehara Tetsuo¹^ORCID,Inoue Nagamu²,Uchino Motoi³^ORCID,Esaki Motohiro⁴,Kobayashi Taku⁵,Saruta Masayuki⁶,Sugimoto Ken⁷,Nakamura Shiro⁸,Hata Keisuke⁹,Hirai Fumihito¹⁰^ORCID,Hiraoka Sakiko¹¹^ORCID,Fujii Toshimitsu¹²,Matsuura Minoru¹³,Matsuoka Katsuyoshi¹⁴,Watanabe Kenji¹⁵^ORCID,Nakase Hiroshi¹⁶,Watanabe Mamoru¹²¹⁷

Affiliation:

1. Department of Gastroenterology and Hepatology Osaka University Graduate School of Medicine Osaka Japan

2. Center for Preventive Medicine Keio University School of Medicine Tokyo Japan

3. Department of Inflammatory Bowel Disease, Division of Surgery Hyogo College of Medicine Hyogo Japan

4. Division of Gastroenterology, Department of Internal Medicine Saga University Saga Japan

5. Center for Advanced IBD Research and Treatment Kitasato University Kitasato Institute Hospital Tokyo Japan

6. Division of Gastroenterology and Hepatology, Department of Internal Medicine The Jikei University School of Medicine Tokyo Japan

7. First Department of Medicine Hamamatsu University School of Medicine Shizuoka Japan

8. Second Department of Internal Medicine Osaka Medical College Osaka Japan

9. Department of Surgical Oncology The University of Tokyo Tokyo Japan

10. Department of Gastroenterology, Faculty of Medicine Fukuoka University Fukuoka Japan

11. Department of Gastroenterology and Hepatology Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama Japan

12. Department of Gastroenterology and Hepatology Tokyo Medical and Dental University Tokyo Japan

13. Department of Gastroenterology and Hepatology Kyorin University School of Medicine Tokyo Japan

14. Division of Gastroenterology and Hepatology, Department of Internal Medicine Toho University Sakura Medical Center Chiba Japan

15. Division of Internal Medicine, Center for Inflammatory Bowel Disease Hyogo College of Medicine Hyogo Japan

16. Department of Gastroenterology and Hepatology, School of Medicine Sapporo Medical University Hokkaido Japan

17. Advanced Research Institute Tokyo Medical and Dental University Tokyo Japan

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.15401

Reference45 articles.

1. The epidemiology of inflammatory bowel disease: East meets west

2. Understanding the complications of anti-tumor necrosis factor therapy in East Asian patients with inflammatory bowel disease

3. Emerging leadership lecture: Inflammatory bowel disease in Asia: Emergence of a “Western” disease

4. Environmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-analyses

5. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination therapy of ustekinumab and immunomodulator for inflammatory bowel disease: concerns about the different results observed between two meta‐analyses;Journal of Gastroenterology and Hepatology;2023-03-12

2. Korean clinical practice guidelines on biologics for moderate to severe Crohn’s disease;Intestinal Research;2023-01-31

3. Safety and Effectiveness of Ustekinumab for Crohn’s Disease in Japanese Post-marketing Surveillance in Biologic-Naive and -Experienced Conriemed;Crohn's & Colitis 360;2023-01-01

4. A Biosimilarity Study Between QX001S and Ustekinumab in Healthy Chinese Male Subjects;Frontiers in Pharmacology;2021-05-18

5. Evidence-based clinical practice guidelines for inflammatory bowel disease 2020;Journal of Gastroenterology;2021-04-22